We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Stays Approval of Generic Skin Cancer Drug
FDA Stays Approval of Generic Skin Cancer Drug
May 27, 2008
The FDA has received court permission to stay its approval of Spear Pharmaceutical’s generic version of Valeant’s Efudex until May 30 while the agency reconsiders its approval.